Alexander has made over 1 trades of the Iterum Therapeutics Plc stock since 2021, according to the Form 4 filled with the SEC. Most recently Alexander sold 20,619,949 units of ITRM stock worth $50,106,476 on 11 February 2021.
The largest trade Alexander's ever made was selling 20,619,949 units of Iterum Therapeutics Plc stock on 11 February 2021 worth over $50,106,476. On average, Alexander trades about 20,619,949 units every 0 days since 2021.
You can see the complete history of Alexander Capital stock trades at the bottom of the page.
Over the last 6 years, insiders at Iterum Therapeutics Plc have traded over $51,533,386 worth of Iterum Therapeutics Plc stock and bought 4,586,895 units worth $57,505,095 . The most active insiders traders include Capital Management, L.P.Ra ..., Alexander J Sarissa Capital..., and James Healy. On average, Iterum Therapeutics Plc executives and independent directors trade stock every 38 days with the average trade being worth of $474,585. The most recent stock trade was executed by Michael W. Dunne on 6 August 2024, trading 106,247 units of ITRM stock currently worth $112,091.
iterum therapeutics plc is an ireland-based clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives. these products are aimed at combatting the global crisis of multi-drug resistant (mdr) pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. iterum’s first product is a novel anti-infective compound that has demonstrated potent in-vitro activity vs. a wide variety of gram-negative, gram-positive and anaerobic bacteria resistant to other antibiotics. for more information on iterum therapeutics please visit www.iterumtx.com.
Iterum Therapeutics Plc executives and other stock owners filed with the SEC include: